Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EQD5 | ISIN: CA2449161025 | Ticker-Symbol: R9B
Tradegate
23.10.24
21:35 Uhr
1,650 Euro
-0,058
-3,40 %
1-Jahres-Chart
DEFI TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
DEFI TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,6561,69023:00
1,6401,72421:59
GlobeNewswire (Europe)
317 Leser
Artikel bewerten:
(2)

DeFi Technologies Inc.: DeFi Technologies' Subsidiary Valour Strengthens Nordic Market Strategy with Transfer of Crypto ETPs to Spotlight Stock Market

  • Strategic Move in Nordic Market: Valour Inc., a subsidiary of DeFi Technologies, will transfer 19 of its ETPs from the Nordic Growth Market to the Spotlight Stock Market in Stockholm, aiming to enhance its position in the Nordic ETP market and support growth in crypto-related instruments.
  • Increased Liquidity and Market Expansion: With this move, Valour's ETPs, which generated approximately SEK 14.3 billion (US$1.3 billion) in trading volume over the past year, will increase to 23 listings on Spotlight, positioning the company for greater liquidity and market expansion.

TORONTO, Oct. 18, 2024))), a crypto-native technology company at the forefront of merging traditional capital markets with decentralized finance ("DeFi"), is pleased to announce that its subsidiary Valour Inc. ("Valour"), a leading issuer of exchange-traded products ("ETPs") providing simplified access to digital assets, will delist 19 ETPs from the Nordic Growth Market ("NGM") on exchange business close on 18 October 2024, and relist them to the Spotlight Stock Market ("Spotlight") in Stockholm, Sweden on 21 October 2024. This decision represents a significant step in Valour's growth strategy within the Nordic market and strengthens its position in the ETP segment, particularly for digital asset-related instruments.

Over the past twelve months, Valour's ETPs have generated a trading volume of approximately SEK 14.3 billion (US$1.3 Billion), and the move to Spotlight is anticipated to support continued strong growth and increased liquidity. With this transition, Valour will have a total of 23 instruments listed on Spotlight, establishing Valour as a significant player on this marketplace.

"The collaboration with Spotlight Stock Market allows us to accelerate the pace of launching new instruments in the market. While we will initially have 23 instruments listed on Spotlight, our goal is to double that number. Together with Spotlight, we aim to become Europe's leading platform for crypto ETPs," says Johanna Belitz, Head of Nordics at Valour.

"We are very proud and pleased with our collaboration with Valour, which has given our ETP segment a strong start since its launch as recently as June of this year. By transferring all of its ETPs to the Spotlight Stock Market, Valour is advancing a relationship that holds high expectations, particularly for increasing the number of high-quality instruments traded in a secure environment. Additionally, Valour's ETPs will now be traded on a platform with substantial potential for increased international trading," comments Spotlight Stock Market CEO Anders Kumlin.

Among the ETPs being transferred are popular products based on Bitcoin, Ethereum, and Solana as underlying assets. Valour emphasizes that holders of these instruments will not need to take any action regarding the listing change, which is expected to proceed smoothly with the first trading day on Spotlight scheduled for October 21, 2024.

This transition marks a new phase in Valour's partnership with Spotlight and is a key part of its long-term goal to expand and strengthen its presence in the international market for digital asset ETPs.

About DeFi Technologies
DeFi Technologies Inc.))) is a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized financeand Twitter, and for more details, visit https://defi.tech/

About Valour
Valour Inc. and Valour Digital Securities Limited))).

In addition to their novel physical backed digital asset platform, which includes 1Valour Bitcoin Physical Carbon Neutral ETP, 1Valour Ethereum Physical Staking, and 1Valour Internet Computer Physical Staking, Valour offers fully hedged digital asset ETPs with low to zero management fees, with product listings across European exchanges, banks and broker platforms. Valour's existing product range includes Valour Uniswap.

Cautionary note regarding forward-looking information:
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to the the transfer of ETPs to Spotlight; Valour's growth strategy in the Nordics; investor confidence in Valour's ETPs; investor interest and confidence in digital assets; the regulatory environment with respect to the growth and adoption of decentralized finance; the pursuit by the Company and its subsidiaries of business opportunities; and the merits or potential returns of any such opportunities. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Such risks, uncertainties and other factors include, but is not limited the acceptance of Valour exchange traded products by exchanges; growth and development of decentralised finance and cryptocurrency sector; rules and regulations with respect to decentralised finance and cryptocurrency; general business, economic, competitive, political and social uncertainties. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

THE CBOE CANADA EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

For further information, please contact:

Olivier Roussy Newton
Chief Executive Officer
ir@defi.tech
(323) 537-7681


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.